Combined use of neuroradiology and ¹H‐MR spectroscopy may provide an intervention limiting diagnosis of glioblastoma multiforme

Abstract

In patients undergoing stereotactic biopsy combined neuroradiological and spectroscopic evaluation diagnoses GBM with accuracy that could replace the need for biopsy. We do not advocate the replacement of biopsy in all patients; instead our data suggest a specific intervention limiting role for the use of (1)H-MRS in brain tumor diagnosis.